Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is the only good Helicobacter a dead Helicobacter?

J J Misiewicz1

  • 1Department of Gastroenterology and Nutrition, Central Middlesex Hospital, London, UK.

Helicobacter
|July 1, 1997
PubMed
Summary

Effective Helicobacter pylori (H. pylori) treatment requires careful patient selection and appropriate drug regimens to combat rising antimicrobial resistance. Education on diagnostic methods and treatment strategies is crucial for clinicians managing H. pylori infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Helicobacter pylori-related disorders.

European journal of gastroenterology & hepatology·2012
Same author

Disorders of colonic motility.

Proceedings of the Royal Society of Medicine·2010
Same author

Recommendations of the ESGE workshop on the Ethics of Percutaneous Endoscopic Gastrostomy (PEG) Placement for Nutritional Support. First European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, June 2003.

Endoscopy·2003
Same author

ABC of the upper gastrointestinal tract. Management of Helicobacter pylori infection.

BMJ (Clinical research ed.)·2001
Same author

Motility of Helicobacter pylori in a viscous environment.

European journal of gastroenterology & hepatology·1999
Same author

Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.

Alimentary pharmacology & therapeutics·1998

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Numerous studies on H. pylori eradication exist, but many lack control groups, sufficient patient numbers, or statistical power.
  • Inconsistent dosing, schedules, and durations of treatment regimens hinder efficacy assessment.
  • Lack of universal treatment guidelines creates confusion for healthcare providers regarding H. pylori management.

Purpose of the Study:

  • To critically review current management strategies for H. pylori infection.
  • To highlight challenges in H. pylori treatment efficacy and resistance.
  • To provide insights into optimal diagnostic and therapeutic approaches.

Main Methods:

  • Comprehensive literature review of H. pylori treatment studies.

Related Experiment Videos

  • Analysis of published data on therapeutic regimens and their outcomes.
  • Evaluation of existing guidelines and their limitations.

    • Main Results:

    • H. pylori treatment often involves expensive triple therapy with potential side effects.
    • Inappropriate treatment choices, poor patient compliance, and counseling contribute to antimicrobial resistance.
    • Widespread resistance to metronidazole and increasing resistance to other agents pose significant challenges.
    • Financial implications of H. pylori treatment are substantial.

    Conclusions:

    • New diagnostic kits for H. pylori may reduce unnecessary treatments, but require further validation.
    • Clinician education on accurate diagnostics, patient selection, and optimal regimens is paramount.
    • H. pylori discovery has transformed understanding of foregut diseases like gastritis, ulcers, and gastric cancer.